Onconova Therapeutics Inc. (ONTX) Reaches New 1-Year Low at $3.01
Shares of Onconova Therapeutics Inc. (NASDAQ:ONTX) reached a new 52-week low during trading on Thursday . The stock traded as low as $3.01 and last traded at $3.10, with a volume of 159,966 shares traded. The stock had previously closed at $3.25.
Separately, Maxim Group set a $6.00 price target on shares of Onconova Therapeutics and gave the stock a “buy” rating in a report on Thursday, August 11th.
The stock’s market cap is $18.96 million. The company’s 50 day moving average is $3.72 and its 200 day moving average is $4.66.
Onconova Therapeutics (NASDAQ:ONTX) last released its quarterly earnings data on Monday, August 15th. The biopharmaceutical company reported ($1.96) EPS for the quarter. The firm earned $2.25 million during the quarter. Analysts expect that Onconova Therapeutics Inc. will post ($2.15) earnings per share for the current fiscal year.
Onconova Therapeutics, Inc is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.